Last reviewed · How we verify
CARNITINE
At a glance
| Generic name | CARNITINE |
|---|---|
| Drug class | Carnitine Analog [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of Carnitine Supplementation on Exercise-Induced Muscle Damage: A Randomized Controlled Trial (NA)
- Efficacy and Safety of XyloCore Peritoneal Dialysis Solution. (PHASE3)
- CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease (EARLY_PHASE1)
- Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment (NA)
- Impact of CRRT on Serum Carnitine and Micronutrient Levels
- Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma (PHASE3)
- Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program
- Effect of L-Carnitine Supplementation in Preterm Neonates (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CARNITINE CI brief — competitive landscape report
- CARNITINE updates RSS · CI watch RSS